Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF MAY 8,1995 PSA#1341

Centers for Disease Control and Prevention (CDC), Procurement & Grants Office, 255 East Paces Ferry Road, N.E., Room No. 507 Atlanta, Georgia 30305

B -- EVALUATION OF THE USE AND EFFICACY OF INFECTION CONTROL MEASURES FOR PREVENTION OF NOSOCOMIAL TRANSMISSION OF MULTIDRUG-RESISTANT TUBERCULOSIS TO PATIENTS AND HEALTH-CARE WORKERS SOL 200-95-0957(P) DUE 070595 POC Contact Barry E. Smith, Contracting Officer at (404)842-6787 The Centers for Disease Control and Prevention (CDC) contemplates awarding a maximum of two, one year contracts to evaluate the efficacy of the CDC infection control guidelines in reducing or preventing nosocomial transmission of tuberculosis (TB) in hospitals. In order to be considered for this requirement the offeror must be a hospital which has had both a CDC-investigated outbreak of Multidrug-Resistant TB and have undergone follow-up study since the outbreak and be able to submit letters from appropriate individuals in the departments of hospital administration, nursing, infection control, and employee health expressing support for the project. Written or facsimile requests for copies of the solicitation will be honored if received within 15 days after the RFP issue date, which will be on or about May 24, 1995. Requests received after that date will be filled on a first-in-first-out basis until the supply is exhausted. The date specified for receipt of offers will be approximately 40 days after the RFP issue date. Requests for the RFP must be in writing and must cite RFP number 200-95-0957(P). Telephone requests will not be accepted. Facsimile requests for the solicitation should be directed to (404) 842-6727. All responsible sources may submit a proposal which shall be considered by the Agency. (0124)

Loren Data Corp. http://www.ld.com (SYN# 0017 19950505\B-0001.SOL)


B - Special Studies and Analyses - Not R&D Index Page